Toll-like receptor 4 polymorphism as pretreatment predictor of response to HCV genotype 3a interferon-based treatment

  • Muhammad Sarfaraz Iqbal, Usman Ali Ashfaq, Saba Khaliq, Muhammad Shareef Masoud, Muhammad Qasim, Asma Haque, Muhammad Usman Ghani, Shah Jahan
  • Future Virology, December 2017, Future Medicine
  • DOI: 10.2217/fvl-2017-0076

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2217/fvl-2017-0076

The following have contributed to this page: Dr Muhammad Sarfaraz Iqbal and Muhammad Usman Ghani